CD44 and cancer: Similarly, when assessing these growth factor effects on the CD44+/CD24−/low cancer stem cell population, we found that BMP4 acted as a differentiation factor, able to decrease both basal and TGFβ-induced BCSC numbers (Fig. 4c).